Ming-hui Chen
Department Head & Distinguished Professor/Statistics
Storrs Mansfield
Are you Ming-hui Chen?
How to update your information.
Scholarly Contributions
468 Scholarly Contributions
``Recent Development on Bayesian Clinical Trial Designs Using Historical Data", 3-hour Tutorial lecture
2018
Research Type: Poster/Presentation
Work-health balance of cancer survivors returning to work: A meta-ethnography
2023
Research Type: Journal Article
Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk
2015
Research Type: Journal Article
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.
2000
Research Type: Journal Article
Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce.
2002
Research Type: Journal Article
Using the Immediate Blood Pressure Benefits of Exercise to Improve Exercise Adherence among Adults with Hypertension. American College of Sports Medicine.
2019
Research Type: Poster/Presentation
Using the Immediate Blood Pressure Benefits of Exercise to Improve Exercise Adherence among Adults with Hypertension
2018
Research Type: Poster/Presentation
Updated Results of MRI-Guided Partial Prostate Brachytherapy for Favorable-Risk Prostate Cancer: Implications for Focal Therapy
2012
Research Type: Journal Article
Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at Prostatectomy
2017
Research Type: Journal Article
Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer
2012
Research Type: Journal Article
Two-Criterion: A New Bayesian Differentially Expressed Gene Selection Algorithm
2012
Research Type: Poster/Presentation
Toward Black-Box Sampling: A Random-Direction Interior-Point Markov Chain Approach
1998
Research Type: Journal Article
Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.
2010
Research Type: Journal Article
Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
2008
Research Type: Journal Article
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
2007
Research Type: Journal Article